Back to 
Xponance LLC
Xponance LLC
NVCR
Showing 4 of 21 quarters
Position history for Xponance LLC's holdings in NovoCure Limited
Yes. Xponance holds 10,155 shares of NVCR (NovoCure), worth $161,972, as of its Q3 2026 13F filing. It reduced the position by 176 shares (-1.7%) from Q2 2026. Xponance has held NVCR since Q2 2026, across 2 quarterly 13F filings.
Current Value
$161,972
Current Shares
10,155
Total Value Change
-$69,336
Total Shares Change
+2,393
Quarter-by-Quarter History
Other major holders of NVCR: Capital World Investors, FMR LLC, Baillie Gifford & Co., Capital International Investors